“…We have shown previously that passive immunity is feasible with the admini stration of the subcellular fraction obtained from tumor-resistant animals (Fuku shima et al 1969; Ishikawa et al 1971). There is little proof regarding the property of the effective substance and mechanism of passive immunity with the administration of the subcellular fraction obtained from tumor-sensitized lymphoid cells.…”
“…We have shown previously that passive immunity is feasible with the admini stration of the subcellular fraction obtained from tumor-resistant animals (Fuku shima et al 1969; Ishikawa et al 1971). There is little proof regarding the property of the effective substance and mechanism of passive immunity with the administration of the subcellular fraction obtained from tumor-sensitized lymphoid cells.…”
In order to improve the results with non-curatively resected advanced gastric cancer, we have tried specific cancer immunotherapy adjunctive to surgery. In this article, six long term survivors (median 6.2 years) are reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.